The majority of people with schizophrenia are not being
prescribed the best and most appropriate medication, according to a
new report by the Zito Trust.
The practice gap in schizophrenia found that 18 per
cent of antipsychotic prescriptions in the UK were for new more
expensive atypical drugs. Between 50-75 per cent of patients
treated with older typical drugs experienced debilitating symptoms,
such as severe restlessness, muscle spasms and mental unease.
The report says the closure of the practice gap in the drug
treatment of schizophrenia is a priority and patients requesting
modern drugs should receive them.
The report is available by e-mailing email@example.com
after midday on Tuesday 10 July.